The Medicare GLP-1 Bridge: $50 a month, with conditions

Original Medicare’s drug benefit has not generally paid for drugs used only for weight loss. The Medicare GLP-1 Bridge is a short-term CMS demonstration that changes that for a defined group, from July 1, 2026 through December 31, 2027. Eligible people in a Part D plan pay $50 for a one-month supply of certain covered drugs.

It is a real program with real limits. Most of what matters is in the conditions.

What the program is, and what it is not

The Bridge is a demonstration, not a change to Medicare’s benefit. It is meant to cover a gap while CMS works out longer-term coverage, and it ends on a fixed date. Part D plans stay out of the flow: they do not carry the cost or the risk of the covered drugs, and the prior authorization and the pharmacy payment run through a processor CMS set up for the purpose.

Those drugs are also not covered through the usual Part D benefit for weight loss, which is why the program exists. For people who take GLP-1 drugs for type 2 diabetes, nothing here applies; those prescriptions are handled through the person’s Part D plan, subject to that plan’s coverage rules, which is why diabetes is on the exclusion list for the Bridge itself.

The Bridge is a temporary program with a fixed end date, a short drug list and its own approval route. It is not a standing benefit.

The conditions that decide it

Three layers have to line up. The first is the coverage: you need Part D drug coverage, which can be a standalone plan or an eligible Medicare Advantage plan that includes it. The second is the prescription: it has to be for weight management, and it has to be for a use Part D does not already cover. The third is the clinical profile, which CMS sets out as a BMI threshold that rises or falls with specific other conditions. A higher BMI qualifies on its own; a lower one qualifies only with a listed condition alongside it. Certain diagnoses rule a person out altogether.

The drug list is narrower than many people assume. Not every GLP-1 is on it, and for Zepbound only the KwikPen counts. A prescription written for a product that is not on the list will not go through the Bridge.

Also on The Second Half Guide The airport help you’re entitled to, and nobody mentions Wheelchairs, escorts through the terminal, help through security — all free and yours by law. Almost entirely unused, because nobody tells you. Read it →

How the money works

The $50 is a copay for a one-month supply, and it has two features that surprise people. It does not count toward your Part D deductible or toward the annual out-of-pocket cap. And it does not change with a low-income subsidy: people who receive Extra Help are eligible if they have Part D, but they still pay the $50. The cap and the deductible are covered in the piece on the drug cap; this program sits outside both.

The visit and any care-plan fees are billed separately, so the $50 is the price of the drug, not of the whole course of care.

What the Bridge leaves alone

People who take Ozempic or Mounjaro for type 2 diabetes stay in their Part D plan, which handles those prescriptions under its own coverage rules. The Bridge is for weight management with the three drugs on the list. It is also not a route to compounded versions of these medicines, which are not covered under the program.

It sits next to two other 2027 changes covered here. The Part D out-of-pocket cap rises to $2,400 in 2027, and the first negotiated prices for a second round of drugs take effect in January, as described in the piece on the next round of Medicare drug discounts. The Bridge is separate from both and ends on its own date.

How a person actually gets it

The process starts when the prescriber sends an eligible prescription to a pharmacy. The pharmacy checks Bridge eligibility with a claim and, if prior authorization is needed, sends the request to the prescriber. The prescriber then submits the required form to the CMS central processor, and the pharmacy fills the prescription once it is approved. CMS notes that a prescriber who tries to start the prior authorization before the pharmacy has submitted that first claim will get a “patient not found” error, and that the processor’s decision can take up to 72 hours.

A person cannot sign up on their own, and no website will enroll you in it. That is the practical test for anyone offering to arrange access for a fee: the official route runs through a prescriber and a pharmacy, and costs nothing beyond the $50 and the care itself.

One more detail worth knowing: if your Medicare drug plan is already paying for your GLP-1, that medication continues through the plan rather than switching to the Bridge.

What happens after 2027

The Bridge ends on December 31, 2027. CMS describes it as short-term and has not described what replaces it in the materials reported here. Anyone planning around the $50 price should treat it as a price that exists for a fixed window and check what has been announced as that date nears. That is a fact about the program’s design, not a prediction about what comes next.

What to check

• You need Part D drug coverage, standalone or through an eligible Medicare Advantage plan. Original Medicare alone, with no drug plan, does not qualify.
• Ask your prescriber whether you meet the clinical criteria and whether the drug is on the current list. CMS says the list may change.
• The sequence runs prescriber to pharmacy, pharmacy to prescriber, prescriber to CMS’s central processor. You do not apply yourself.
• The $50 does not count toward your Part D deductible or out-of-pocket cap, and it is not reduced by Extra Help.
• Be wary of anyone offering to arrange access for a fee or asking for a Medicare number by phone or text.

The Bridge is an answer to a specific question, which is who can get certain weight-loss drugs at a set price until the end of 2027. Whether it applies to a given person is a conversation between that person and a prescriber, with the list and the criteria in hand.